Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    2018 year
    03
    17 day
    Winhealth worked with hundreds pharmaceutical enterprises 2018CHIPS Summit came to a successful end

    On March 15-17, the 2018 China Summit for NASDAQ Innovative Pharmaceutical Enterprises and Hangzhou CBD Investment Forum, which was co-hosted by Winhealth Group, was successfully concluded at InterContinental Hotel in Hangzhou.


    This summit was specially hosted by Hangzhou Xiacheng District People's Government, hosted by TPP Medical Company (U.S.), and jointly organized by Winhealth Group and Xiacheng District State-owned Investment Holding Group. It is the first large-scale exchange activity for the European and American enterprises and Nasdaq listed companies currently held by the domestic pharmaceutical industry in China. 


    A total of 43 Nasdaq listed bio-pharmaceutical and medical device companies and 19 European and American innovative companies were invited to the summit, including 300 pharmaceutical companies and medical investment institutions from all over the country, such as Fosun Pharmaceutical, Yunnan Baiyao Powder, Shanghai Pharmaceuticals, CR Sanjiu, and Sinopharm Holdings.


    Winhealth worked with hundreds pharmaceutical enterprises 2018CHIPS Summit came to a successful end  Winhealth worked with hundreds pharmaceutical enterprises 2018CHIPS Summit came to a successful end


    On the day of the conference on March 15, Chen Weiqiang, secretary of Xiacheng District Committee, delivered a speech. He said: 'This activity focuses on the bio-pharmaceutical industry and shows the innovative ideas and achievements of bio-pharmaceutical enterprises. It provides an opportunity to promote the development of the bio-pharmaceutical industry, promote the communication and cooperation between capital and enterprises, and between enterprises, and realize the precise link between excellent projects with financial capital and industrial platforms.'


    Winhealth worked with hundreds pharmaceutical enterprises 2018CHIPS Summit came to a successful end  Winhealth worked with hundreds pharmaceutical enterprises 2018CHIPS Summit came to a successful end


    At the following signing ceremony, Mr. Wang Wei, president of Winhealth Group, and representatives of all parties concerned, jointly signed the agreement on 'China Medical Health (cross-border) Special Opportunities Fund'. The 'China Medical Health (cross-border) Special Opportunities Fund' with a total size of 1 billion yuan, offers financial support to foreign advanced technology entities and domestic high-quality pharmaceutical enterprises who settle in Hangzhou. The fund will focus on international high-tech enterprises with innovative technologies in medical devices (including but not limited to in vitro diagnosis, medical AI, medical cloud services and medical information systems) and with market competitiveness, and will also invest in related high-tech medical technology enterprises. 


    In the afternoon, Mr. Wang Wei, president of Winhealth Group, presided over the first round-table forum. He gave a wonderful speech on 'Sharing of experience in cooperation between Chinese and American pharmaceutical enterprises - product cooperation', and had in-depth exchanges and discussions with the presidents and representatives of Yifan International, Hexi Health, Yuheng Pharmaceutical, and China Resources Zhengda Life Science Foundation. The round-table forum attracted many domestic and foreign guests.


    A welcome dinner was also held on the same day, where distinguished domestic and foreign friends and guests gathered together. The agenda of the first day of the conference was successfully concluded in a happy atmosphere.


    Winhealth worked with hundreds pharmaceutical enterprises 2018CHIPS Summit came to a successful end  Winhealth worked with hundreds pharmaceutical enterprises 2018CHIPS Summit came to a successful end


    The next two days' meeting mainly focused on the road shows for European and American enterprises and one-on-one talks. During the road show, the European and American enterprises participating in the road shows showcased their excellent products and latest research achievements, gave a detailed introduction to these products and achievements, and answered questions from the audience. The Chinese enterprises held one-on-one talks with the European and American enterprises on their cooperation intentions, and the reservation was quite popular. After reservation was successful, the Chinese and American enterprises held in-depth talks on various cooperation issues.


    A welcome dinner was also held on the same day, where distinguished domestic and foreign friends and guests gathered together. The agenda of the first day of the conference was successfully concluded in a relaxing and harmonious atmosphere.  


    Winhealth Group won the attention of many domestic and foreign pharmaceutical enterprises at this conference. Many guests of pharmaceutical enterprises came to inquire about and discuss relevant matters in person, laying a good foundation for further exchanges and cooperation in the future. This conference not only provided an excellent platform for exchanges and cooperation between domestic and foreign pharmaceutical enterprises, but also created favorable conditions and opportunities for Winhealth Group to showcase itself and achieve ideal cooperation. We believe that Winhealth Group will attain a yet higher goal in the near future!


    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline )
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.